HIGHLIGHTS
- who: Tong Liu from the Beijing University of Chinese Medicine, China have published the research: Xin-Li-Fang efficacy and safety for patients with chronic heart failure: A study protocol for a randomized, double-blind, and placebo-controlled trial, in the Journal: (JOURNAL) of 13/04/2022
- what: The research team`s previous studies have shown that in a rat model of CHF, XLF can improve heart function and increase the proportion of regulatory T (Treg) cells in the spleen and the lymph (this research has not been published). Meanwhile, it can also reduce the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.